je.st
news
Tag: cancer
New Cohorts From CheckMate -012 Assess Optimal Dosing Of Opdivo+Yervoy In The First-Line Treatment Of Patients With Advanced Non-Small Cell Lung Cancer
2015-09-08 07:25:25| drugdiscoveryonline Home Page
Bristol-Myers Squibb Company recently announced updated results from the Opdivo (nivolumab)+Yervoy (ipilimumab) arms in CheckMate -012, a multi-arm Phase 1b trial evaluating Opdivo in patients with chemotherapy-naïve advanced non-small cell lung cancer (NSCLC)
Tags: with
advanced
cell
treatment
Firm's cancer drugs strategy
2015-09-03 15:23:40| Biotech - Topix.net
Abingdon-based biotechnology firm Immunocore is aiming to make its radical cancer treatment drugs commercially available to patients in the next four years, said the new chief executive officer, Eliot Forster. Dr Forster, who joined the company in January, said: "I would anticipate that, within the next three or four years, we would be selling our lead molecule to patients."
Tags: strategy
cancer
drugs
firms
Transgenomic Adds Asia Distributors For Its ICEme Kits That Enable Liquid Biopsy-Based Genomics Cancer Research On Existing Platforms
2015-09-02 07:14:03| drugdiscoveryonline News Articles
Transgenomic, Inc., a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, recently announced the addition of distributors in China and Japan for its ICEme Mutation Enrichment Kits for genomics research
Tags: research
existing
asia
enable
International Scientific Forum on Alcohol Research Critique 170: An update on the association of alcohol consumption with the risk of cancer
2015-09-01 16:04:58| Daily beverage news and comment - from just-drinks.com
A recent analysis - based on data from two very large cohort studies, the Nurses' Health Study and the Health Professionals' Follow-up Study - evaluated the association of alcohol consumption over many years with the risk of cancer.
Gustave Roussy, leading European comprehensive cancer center, chooses Elekta's Versa HD
2015-09-01 08:35:25| Appliances - Topix.net
Gustave Roussy has awarded Elekta with an order for four Versa HDa linear accelerators, replacing their existing installed base of competing systems. Gustave Roussy, a premier European comprehensive cancer center, started a program in 2013 to gain a clear leadership in the field of radiotherapy.
Tags: center
leading
european
comprehensive
Sites : [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] next »